Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma

Area of Science:

• Ophthalmology
• Glaucoma Surgery
• Medical Devices

Background:

• Traditional glaucoma surgery carries risks.
• New minimally invasive glaucoma surgeries (MIGS) offer less invasive alternatives.
• MIGS may reduce reliance on glaucoma medications.

Purpose of the Study:

• To review the efficacy of primary MIGS as an initial glaucoma treatment.
• To evaluate new MIGS devices and procedures for lowering intraocular pressure.
• To assess the potential of MIGS to reduce medication burden.

Main Methods:

• Review of recent studies on MIGS procedures.
• Inclusion of devices like Trabectome, iStent, Hydrus, XEN, and CyPass Micro-Stent.
• Focus on intraocular pressure reduction and medication burden in phakic and pseudophakic patients.

Main Results:

• Several MIGS procedures demonstrate effectiveness in lowering intraocular pressure (IOP) and/or medication needs.
• Observed IOP reduction and/or medication burden decrease lasted at least 12 months.
• Primary MIGS is emerging as a viable initial treatment option.

Conclusions:

• Minimally invasive glaucoma surgery is a promising alternative to traditional methods.
• Further research is required to establish long-term cost-effectiveness and quality-of-life outcomes.
• Investigator-initiated randomized trials are needed for robust data.